Combined analysis of two parallel randomized trials of sirolimus-coated and paclitaxel-coated balloons in coronary in-stent restenosis lesions
Background: Paclitaxel-coated balloons (PCBs) are a preferred treatment option for coronary in-stent restenosis. To date, data from randomized trials of alternative drug coatings are lacking. The aim of the randomized Malaysian and German-Swiss randomized trials was to investigate a novel sirolimus-...
Saved in:
Main Authors: | Scheller, Bruno, Mangner, Norman, Kader, Muhamad Ali S. K. Abdul, Ahmad, Wan Azman Wan, Jeger, Raban, Wohrle, Jochen, Ong, Tiong Kiam, Liew, Houng Bang, Gori, Tommaso, Mahfoud, Felix, Nuruddin, Amin Ariff, Woitek, Felix, Abidin, Imran Zainal, Schwenke, Carsten, Schnorr, Beatrix, Ali, Rosli Mohd |
---|---|
Format: | Article |
Published: |
Lippincott Williams & Wilkins
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/40427/ https://doi.org/10.1161/CIRCINTERVENTIONS.122.012305 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of coronary de novo lesions by a sirolimus- or paclitaxel-coated balloon
by: Ahmad, Wan Azman Wan, et al.
Published: (2022) -
Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty
by: Mohd Shah, Azarisman Shah, et al.
Published: (2011) -
Drug-coated balloons for coronary artery disease third report of the international DCB consensus group
by: Jeger, Raban V., et al.
Published: (2020) -
Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: Rationale, methodology and design of the SCORE trial
by: Otto, Sylvia, et al.
Published: (2023) -
Mechanisms and treatment of femoropoplitealin-stent restenosis
by: Kareem, A K, et al.
Published: (2019)